| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0006308 | Dna catabolic process | Affects phenotype | PMID:16882877 |
| GO:0006741 | Nadp biosynthetic process | Affects phenotype | PMID:32416107 |
| GO:0006914 | Autophagy | Affects phenotype | PMID:38220133 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:35533795 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:35533795 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:1058559; PMID:16903937; PMID:32416107; PMID:35533795; PMID:38123000; PMID:39081119 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:39081119 |
| GO:0008219 | Cell death | Increases phenotype | PMID:15786497 |
| GO:0008283 | Cell population proliferation | Decreases phenotype | PMID:15786497; PMID:16882877 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:28578006 |
| GO:0016042 | Lipid catabolic process | Affects phenotype | PMID:32416107 |
| GO:0030308 | Negative regulation of cell growth | Increases phenotype | PMID:37597760 |
| GO:0036098 | Male germ-line stem cell population maintenance | Decreases phenotype | PMID:28578006 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:35533795; PMID:38123000 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:34097952 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:28578006 |
| GO:0046466 | Membrane lipid catabolic process | Affects phenotype | PMID:38220133 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:38123000 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:38123000 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:32416107; PMID:38220133 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:16882877 |
| GO:0097368 | Establishment of sertoli cell barrier | Affects phenotype | PMID:35533795 |
| GO:0097707 | Ferroptosis | Increases phenotype | PMID:32416107 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:32416107; PMID:35533795; PMID:38123000; PMID:39081119 |
| GO:0160020 | Positive regulation of ferroptosis | Increases phenotype | PMID:38220133 |
| GO:1902093 | Positive regulation of flagellated sperm motility | Decreases phenotype | PMID:26524245 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.